Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 2836 AL 2850

[Psychogenic movement disorders]

Drapier S, Vérin M.

Rev Neurol (Paris). 2012 Aug-Sep;168(8-9):662-7. doi: 10.1016/j.neurol.2012.06.010. Epub 2012 Aug 13.

THAP1 mutations and dystonia phenotypes: genotype phenotype correlations

Xiromerisiou G, Houlden H, Scarmeas N, Stamelou M, Kara E, Hardy J, Lees AJ, Korlipara P, Limousin P, Paudel R, Hadjigeorgiou GM, Bhatia KP.

Mov Disord. 2012 Sep 1;27(10):1290-4. doi: 10.1002/mds.25146. Epub 2012 Aug 17.

Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis

Moteshafi H, Stip E.

Expert Opin Drug Saf. 2012 Sep;11(5):713-32. doi: 10.1517/14740338.2012.712682.

FDG-PET and molecular brain imaging in the movement disorders clinic

Bohnen NI, Minoshima S.

Neurology. 2012 Sep 25;79(13):1306-7. doi: 10.1212/WNL.0b013e31826c1be1. Epub 2012 Aug 22.

[¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism

Hellwig S, Amtage F, Kreft A, Buchert R, Winz OH, Vach W, Spehl TS, Rijntjes M, Hellwig B, Weiller C, Winkler C, Weber WA, Tüscher O, Meyer PT.

Neurology. 2012 Sep 25;79(13):1314-22. doi: 10.1212/WNL.0b013e31826c1b0a. Epub 2012 Aug 22.

Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study

Dubois B, Tolosa E, Katzenschlager R, Emre M, Lees AJ, Schumann G, Pourcher E, Gray J, Thomas G, Swartz J, Hsu T, Moline ML.

Mov Disord. 2012 Sep 1;27(10):1230-8. doi: 10.1002/mds.25098. Epub 2012 Aug 22.

[Consensus conference of the Mexican Association for the Study of Climateric on veralipride prescription for patients with vasomotor symptoms]

Basavilvazo-Rodríguez A, Bravo-Rodríguez LM, Carranza-Lira S, Celis-González C, Hernández Marín I, Hernández-Valencia M, López Navarro ME, Alvarado Maldonado Jde D, Armando Montaño J, Moreno Avellán AJ, Vázquez G.

Ginecol Obstet Mex. 2012 Jul;80(7):467-72.

My journey from orthodontics to craniofacial pain and TMJ to movement disorders

Stack BC.

Cranio. 2012 Jul;30(3):156-8. doi: 10.1179/crn.2012.023.

The gap between clinical gaze and systematic assessment of movement disorders after stroke

van der Krogt HJ, Meskers CG, de Groot JH, Klomp A, Arendzen JH.

J Neuroeng Rehabil. 2012 Aug 27;9:61. doi: 10.1186/1743-0003-9-61.

Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder

Stamelou M, Tuschl K, Chong WK, Burroughs AK, Mills PB, Bhatia KP, Clayton PT.

Mov Disord. 2012 Sep 1;27(10):1317-22. doi: 10.1002/mds.25138. Epub 2012 Aug 23.

Characterization of periodic upper limb movement disorder in a patient with restless arms syndrome

Ruppert E, Cretin B, Meyer C, Kilic-Huck U, Bourgin P.

Mov Disord. 2012 Sep 15;27(11):1459-61. doi: 10.1002/mds.25154. Epub 2012 Aug 23.

Metabolic brain networks in translational neurology: concepts and applications

Niethammer M, Eidelberg D.

Ann Neurol. 2012 Nov;72(5):635-47. doi: 10.1002/ana.23631. Epub 2012 Aug 31.

Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease

Koppula S, Kumar H, More SV, Kim BW, Kim IS, Choi DK.

Int J Mol Sci. 2012;13(8):10608-10629. doi: 10.3390/ijms130810608. Epub 2012 Aug 23.

Downbeat nystagmus due to a paramedian medullary lesion

Nakamagoe K, Shimizu K, Koganezawa T, Tamaoka A.

J Clin Neurosci. 2012 Nov;19(11):1597-9. doi: 10.1016/j.jocn.2012.03.017. Epub 2012 Sep 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias